Free shipping on all orders over $ 500

Tropisetron Hydrochloride

Cat. No. M13880

All AbMole products are for research use only, cannot be used for human consumption.

Tropisetron Hydrochloride Structure
Synonym:

SDZ-ICS-930

Size Price Availability Quantity
10mg USD 50  USD50 In stock
50mg USD 80  USD80 In stock
100mg USD 108  USD108 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tropisetron Hydrochloride (SDZ-ICS-930) is a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist with an IC50 of 70.1 ± 0.9 nM for 5-HT3 receptor. IC50 value: 70.1 ± 0.9 nM Target: 5-HT3 receptor; α7-nicotinic receptor in vitro: Retinal ganglion cells(RGCs) pretreated with 100 nM tropisetron before glutamate increased cell survival to an average of 105% compared to controls. Inhibition studies using the alpha7 nAChR antagonist, MLA (10 nM), support the hypothesis that tropisetron is an effective neuroprotective agent against glutamate-induced excitotoxicity; mediated by α7 nAChR activation. Tropisetron had no discernible effects on pAkt levels but significantly decreased p38 MAPK levels associated with excitotoxicity from an average of 15 ng/ml to 6 ng/ml. Tropisetron, but not granisetron, significantly inhibits the phosphatase activity of calcineurin, over-expresses the CB(1) receptors at both transcriptional and protein levels, and reduces cAMP content in cerebellar granule neurons (CGNs). in vivo: Animals were treated intracerebroventricularly with tropisetron, mCPBG (selective 5-HT3 receptor agonist) or mCPBG plus tropisetron on days 1, 3, 5 and 7. Tropisetron significantly diminished the elevated levels of these markers and reversed the cognitive deficit. Interestingly, tropisetron was also found to be a potent inhibitor of calcineurin phosphatase activity. tropisetron (5mg/kg/day) plus mCPBG (10mg/kg/day), and granisetron (5mg/kg/day) intraperitoneally on days 3-35 post-immunization. Treatment with tropisetron and granisetron markedly suppressed the clinical symptoms of EAE (p<0.001) and reduced leukocyte infiltration as well as demyelination in the spinal cord (p<0.05).

Chemical Information
Molecular Weight 320.81
CAS Number 105826-92-4
Solubility (25°C) Water ≥ 50 mg/mL
Storage 2-8°C, dry, sealed
References

[1] Alireza Karimollah, et al. Tropisetron balances immune responses via TLR2, TLR4 and JAK2/STAT3 signalling pathway in LPS-stimulated PBMCs

[2] Joel Hassell, et al. Tropisetron enhances recognition memory in ovariectomized female rats

[3] Mohammad Reza Zirak, et al. Tropisetron ameliorates cyclophosphamide-induced hemorrhagic cystitis in rats

[4] Chen Peng, et al. Compatible stability of methylprednisolone sodium succinate and tropisetron in 0.9% sodium chloride injection

[5] Shiva Gholizadeh-Ghaleh Aziz, et al. Ameliorative effects of tropisetron on liver injury in streptozotocin-induced diabetic rats

Related 5-HT Receptor Products
Aripiprazole-d8

Aripiprazole-d8

Clozapine-d8

Clozapine-d8

Olanzapine-d3

Olanzapine-d3

Quetiapine-d8 fumarate

Quetiapine-d8 fumarate

Dapoxetine hydrochloride-d7

Dapoxetine hydrochloride-d7

  Catalog
Abmole Inhibitor Catalog




Keywords: Tropisetron Hydrochloride, SDZ-ICS-930 supplier, 5-HT Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.